356 related articles for article (PubMed ID: 12407648)
21. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
Böger CA; Götz AK; Krüger B; Hösl M; Schmitz G; Riegger GA; Krämer BK
Eur J Med Res; 2005 Apr; 10(4):161-8. PubMed ID: 15946912
[TBL] [Abstract][Full Text] [Related]
22. Inflection point of ascending aortic waveform is a predictive factor for all-cause and cardiovascular mortality in patients with chronic renal failure on hemodialysis.
Ueda H; Hayashi T; Tsumura K; Yoshimaru K; Nakayama Y; Yoshikawa J
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1151-5. PubMed ID: 15607622
[TBL] [Abstract][Full Text] [Related]
23. Comparison of survival between diabetic and non-diabetic patients on maintenance hemodialysis: a single-centre experience.
Racki S; Zaputović L; Vujicić B; Crncević-Orlić Z; Dvornik S; Mavrić Z
Diabetes Res Clin Pract; 2007 Feb; 75(2):169-75. PubMed ID: 16824639
[TBL] [Abstract][Full Text] [Related]
24. ACE inhibitors in hemodialysis patients: does survival improve?
Hörl WH
Am J Kidney Dis; 2002 Nov; 40(5):1100-2. PubMed ID: 12407658
[No Abstract] [Full Text] [Related]
25. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
26. [Effect of an ambulatory program devoted to chronic renal insufficiency on the reduction of mobidity and hospitalization among patients at the beginning of dialysis treatment].
Malberti F; Ravani P
G Ital Nefrol; 2003; 20(2):127-32. PubMed ID: 12746797
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin Converting Enzyme Inhibitor Dialyzability and Outcomes in Older Patients Receiving Hemodialysis.
Weir MA; Fleet JL; Dixon SN; Jain AK; Oliver M; Wald R; McIntyre C; Garg AX
Blood Purif; 2015; 40(3):232-42. PubMed ID: 26382240
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular problems on hemodialysis: current deficits and potential improvement.
Ritz E; Bommer J
Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S71-8. PubMed ID: 19996009
[TBL] [Abstract][Full Text] [Related]
29. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
30. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
31. Mortality rate of patients with end stage renal disease on regular hemodialysis: a single center study.
Elsharif ME
Saudi J Kidney Dis Transpl; 2011 May; 22(3):594-6. PubMed ID: 21566330
[TBL] [Abstract][Full Text] [Related]
32. Long-term progression of chronic renal insufficiency in the AIPRI Extension Study. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
Locatelli F; Carbarns IR; Maschio G; Mann JF; Ponticelli C; Ritz E; Alberti D; Motolese M; Janin G; Zucchelli P
Kidney Int Suppl; 1997 Dec; 63():S63-6. PubMed ID: 9407424
[TBL] [Abstract][Full Text] [Related]
33. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
Wong CF; McCarthy M; Howse ML; Williams PS
Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
[TBL] [Abstract][Full Text] [Related]
34. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.
Genovesi S; Vincenti A; Rossi E; Pogliani D; Acquistapace I; Stella A; Valsecchi MG
Am J Kidney Dis; 2008 Feb; 51(2):255-62. PubMed ID: 18215703
[TBL] [Abstract][Full Text] [Related]
35. Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors.
Paoletti E; Cassottana P; Bellino D; Specchia C; Messa P; Cannella G
Am J Kidney Dis; 2002 Oct; 40(4):728-36. PubMed ID: 12324907
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular risk factors and diseases strongly predict hemodialysis treatment outcome in maintenance hemodialysis patients.
Racki S; Zaputović L; Vujicić B; Mavrić Z; Grzetić M; Ravlić-Gulan J
Croat Med J; 2005 Dec; 46(6):936-41. PubMed ID: 16342347
[TBL] [Abstract][Full Text] [Related]
37. Anaemia due to ACE inhibitors and losartan in patients with renal failure.
Prescrire Int; 1999 Dec; 8(44):179-80. PubMed ID: 11503817
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular factors influencing survival in dialysis patients.
Alpert MA
Adv Perit Dial; 1996; 12():110-9. PubMed ID: 8865884
[TBL] [Abstract][Full Text] [Related]
39. Risk factors of vascular access failure in patients on hemodialysis.
Gheith OA; Kamal MM
Iran J Kidney Dis; 2008 Oct; 2(4):201-7. PubMed ID: 19377238
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic advantages of angiotensin converting enzyme inhibitors in chronic renal disease.
Omata K; Kanazawa M; Sato T; Abe F; Saito T; Abe K
Kidney Int Suppl; 1996 Jun; 55():S57-62. PubMed ID: 8743512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
